Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads by Date

Must reads for theWeek ending August 13, 2017

A Prognostic Model for Post-Splenectomy Survival , Am J Hematol; ePub 2017 Aug 7; Tefferi, et al

Using Abnormal Bone Marrow Features for DDx, Haematologica; 2017 Aug; Wang, Hasserjian, et al

Consider This in Older People Undergoing Allo-SCT , Biol Blood Marrow Transplant; ePub 2017 Jul 19; Jakubowski, et al

Survey Results Show How MPNs Impact Life Quality , Ann Hematol; ePub 2017 Aug 5; Harrison, et al

Genetic Risk Assessment in Patients with MPNs , Mayo Clin Proc; 2017 Aug; Tefferi, Vannucchi

More must reads

Must reads for theWeek ending August 6, 2017

Sepsis Incidence in Patients with AML Evaluated, Clin Lymphoma Myeloma Leuk; ePub 2017 Jul 25; Malik, et al

Lenalidomide After ASCT for Multiple Myeloma, J Clin Oncol; ePub 2017 Jul 25; McCarthy, et al

Outcomes in Patients with MYC-Positive DLBCL, Cancer; ePub 2017 Jul 27; Epperla, Maddocks, et al

Toxicity and Mortality in Older AHCT Recipients, Am J Hematol; ePub 2017 Jul 19; Belete, et al

Fatigue-Reducing Psychological Therapy, Cochrane; 2017 Jul 14; Poort, Peters, et al

More must reads

Must reads for theWeek ending July 30, 2017

How Comorbidities Impact DLBCL Outcomes in Elderly, Am J Hematol; ePub 2017 Jul 19; Saygin, et al

Survival in Patients with Plasma Cell Myeloma, Leuk Lymphoma; ePub 2017 Jul 21; Santiago, et al

More must reads

Must reads for theWeek ending July 23, 2017

Rare Subtype May Have Prognostic Significance, Blood Cancer J; ePub 2017 Jul 14; Gong, et al

Insurance Status and Overall Survival in CML, Cancer; ePub 2017 Jun; Perry, Brunner, et al

Look for Myeloid Neoplasm in These Patients, Blood; ePub 2017 Jul 5; Papo, Diamond, et al

Value of Donor Lymphocyte Infusions Studied, Biol Blood Marrow Transplant; ePub 2017 Jul 13; Caldemeyer, et al

What Contributes to the Appearance of Dual MPNs?, Am J Hematol; 2017 Jun; Kandarpa, Wu, et al

More must reads

Must reads for theWeek ending July 16, 2017

This May Predict Response to Gemtuzumab Ozogamicin, J Clin Oncol; ePub 2017 Jun 23; Lamba, et al

Endari Approved for Sickle Cell Complications, FDA news release; 2017 Jul 7

More must reads

Pages